CENTRE D'EXPERTISE MEDICALE : revenue, balance sheet and financial ratios

CENTRE D'EXPERTISE MEDICALE is a French company founded 33 years ago, specialized in the sector Autres activités de soutien aux entreprises n.c.a.. Based in BLAGNAC (31700), this company of category PME shows in 2024 a revenue of 1.8 M€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.

Data updated on 2026-05-09

Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy

Financial history - CENTRE D'EXPERTISE MEDICALE (SIREN 390530830)
Indicator 2024 2023 2022 2021 2020 2019 2018 2017 2016
Revenue 1 797 721 € 1 668 112 € 1 680 232 € 1 419 558 € 1 451 398 € 1 625 046 € 1 260 388 € 1 181 077 € 1 137 820 €
Net income -6 796 € 132 286 € 102 480 € 94 330 € 145 184 € 185 515 € 186 467 € 189 903 € 176 435 €
EBITDA 3 966 € 201 387 € 280 960 € 174 271 € 250 605 € 313 865 € 272 587 € 291 769 € 273 060 €
Net margin -0.4% 7.9% 6.1% 6.6% 10.0% 11.4% 14.8% 16.1% 15.5%

Revenue and income statement

In 2024, CENTRE D'EXPERTISE MEDICALE achieves revenue of 1.8 M€. Over the period 2016-2024, the company shows strong growth with a CAGR (compound annual growth rate) of +5.9%. Vs 2023: +8%. After deducting consumption (0 €), gross margin stands at 1.8 M€, i.e. a rate of 100%. This ratio measures the ability to generate value from commercial activity. EBITDA (= Gross margin - Personnel expenses - Taxes) reaches 4 k€, representing 0.2% of revenue. Warning negative scissor effect: despite revenue change (+8%), EBITDA varies by -98%, reducing margin by 11.9 pts. This reflects costs rising faster than revenue. The operating margin remains fragile, requiring cost vigilance. Net income is negative at -7 k€ (-0.4% of revenue), which will impact equity.

Revenue (2024) ?
Revenue
Definition
Total amount of sales of goods and services made by the company.
Formula
Sales of goods + Sold production

1 797 721 €

Gross margin (2024) ?
Gross margin
Definition
Difference between revenue and cost of goods sold.
Formula
Revenue - Cost of goods consumed

1 797 721 €

EBITDA (2024) ?
Gross Operating Surplus (EBITDA)
Definition
Resources generated by current operations, before depreciation and financial expenses.
Formula
Value added - Personnel expenses - Taxes
Interpretation
Positive = profitable activity

3 966 €

EBIT (2024) ?
EBIT (Operating Income)
Definition
Operating income, including depreciation and provisions.
Formula
EBITDA - Depreciation and provisions + Reversals

-26 137 €

Net income (2024) ?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax

-6 796 €

EBITDA margin (2024) ?
EBITDA margin
Definition
Measures the company's operating profitability.
Formula
(EBE / CA) x 100
Interpretation
> 10% : Good profitability
5-10% : Average
< 5% : Low

0.2%

Loading income statement...

Chart evolution

Show :

Assets

Loading data...

Liabilities

Loading data...

Solvency and debt ratios

The debt ratio (= Financial debt / Equity x 100) stands at 58%. Debt remains under control: the company retains capacity to raise new debt if needed. Financial autonomy (= Equity / Total assets x 100) reaches 31%. The balance between equity and debt is satisfactory. Debt repayment capacity (= Financial debt / Cash flow) indicates it would take 7.0 years of cash flow to repay all financial debt. Beyond 7 years, banks generally consider credit risk as high. Cash flow represents 1.2% of revenue. Cash flow measures resources generated by operations, available for investment and debt repayment.

Debt ratio (2024) ?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low
50-100% : Moderate
> 100% : High

57.957%

Financial autonomy (2024) ?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy
20-30% : Average
< 20% : Low

31.07%

Cash flow / Revenue (2024) ?
Cash flow / Revenue
Definition
Self-financing capacity relative to revenue.
Formula
(CAF / CA) x 100
Interpretation
The higher the ratio, the more cash the company generates

1.242%

Repayment capacity (2024) ?
Repayment capacity
Definition
Number of years needed to repay debts with cash flow.
Formula
Financial debt / Cash flow
Interpretation
< 3 years : Excellent
3-5 years : Fair
> 5 years : Warning

7.009

Asset age ratio (2024) ?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Interpretation
< 50% : Recent assets
50-70% : Normal wear
> 70% : Aging assets

42.3%

Solvency indicators evolution
CENTRE D'EXPERTISE MEDICALE

Sector positioning

Debt ratio
57.96 2024
2022
2023
2024
Q1: 0.0
Med: 5.61
Q3: 47.03
Average

In 2024, the debt ratio of CENTRE D'EXPERTISE MEDICALE (57.96) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.

Financial autonomy
31.07% 2024
2022
2023
2024
Q1: 6.21%
Med: 32.46%
Q3: 67.88%
Average +15 pts over 3 years

In 2024, the financial autonomy of CENTRE D'EXPERTISE MEDICALE (31.1%) ranks below the median of the sector. This ratio represents the share of equity in total financing. An improvement would strengthen the competitive position.

Repayment capacity
7.01 years 2024
2022
2023
2024
Q1: 0.0 years
Med: 0.0 years
Q3: 1.29 years
Average

In 2024, the repayment capacity of CENTRE D'EXPERTISE MEDICALE (7.01) ranks above the median of the sector. This ratio indicates the number of years needed to repay debt with cash flow. A reduction effort could improve financial strength.

Liquidity ratios

The liquidity ratio (= Current assets / Current liabilities) stands at 339.93. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months. The interest coverage ratio (= EBIT / Interest expenses) is 59.6x. Operating income very largely covers interest expenses: high safety margin.

Liquidity ratio (2024) ?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good
1-1.5 : Fair
< 1 : Liquidity risk

339.928

Interest coverage (2024) ?
Interest coverage
Definition
Ability to cover interest charges with operating income.
Formula
EBIT / Interest expenses
Interpretation
> 3 : Comfortable
1.5-3 : Acceptable
< 1.5 : Risk

59.581

Liquidity indicators evolution
CENTRE D'EXPERTISE MEDICALE

Sector positioning

Liquidity ratio
339.93 2024
2022
2023
2024
Q1: 120.11
Med: 218.14
Q3: 571.7
Good +8 pts over 3 years

In 2024, the liquidity ratio of CENTRE D'EXPERTISE MEDICALE (339.93) ranks above the median of the sector. This ratio measures the ability to cover short-term debt with current assets. This comfortable position offers an appreciable safety margin.

Interest coverage
59.58x 2024
2022
2023
2024
Q1: 0.0x
Med: 0.0x
Q3: 1.61x
Excellent +6 pts over 3 years

In 2024, the interest coverage of CENTRE D'EXPERTISE MEDICALE (59.6x) ranks in the top 25% of the sector. This ratio indicates how many times operating income covers interest expenses. High coverage means financial charges weigh little on profitability.

Working capital requirement (WCR) and payment terms

Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments. Average customer payment term: 14 days (formula: Customer receivables / Revenue incl. VAT x 360). Supplier term: 22 days. Favorable situation: supplier credit is longer than customer credit by 8 days. WCR is negative (-37 days): operations structurally generate cash. Notable WCR improvement over the period (-256%), freeing up cash.

Operating WCR (2024) ?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released
Positive = financing needed

-185 039 €

Customer credit (2024) ?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good
45-60j : Average
> 60j : Long

14 j

Supplier credit (2024) ?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow

22 j

Inventory turnover (2024) ?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover

0 j

WCR in days of revenue (2024) ?
WCR in days of revenue
Definition
Expresses working capital requirement in days of revenue.
Formula
(Operating WCR / Revenue) x 360
Interpretation
The fewer days, the better the working capital management

-37 j

WCR and payment terms evolution
CENTRE D'EXPERTISE MEDICALE

Positioning of CENTRE D'EXPERTISE MEDICALE in its sector

Comparison with sector Autres activités de soutien aux entreprises n.c.a.

Valuation estimate

Based on 131 transactions of similar company sales (all years), the value of CENTRE D'EXPERTISE MEDICALE is estimated at 252 430 € (range 123 681€ - 475 096€). With an EBITDA of 3 966€, the sector multiple of 4.8x is applied. The price/revenue ratio is 0.36x (conservative valuation). This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.

Estimated enterprise value 2024
131 transactions
123k€ 252k€ 475k€
252 430 € Range: 123 681€ - 475 096€
NAF 5 all-time

Valuation detail by method

Ajustez les pondérations selon votre analyse

EBITDA Multiple 50%
3 966 € × 4.8x
Estimation 19 234 €
5 776€ - 33 089€
Revenue Multiple 30%
1 797 721 € × 0.36x
Estimation 641 091 €
320 192€ - 1 211 776€

Valuation evolution

How is this estimate calculated?

This estimate is based on the analysis of 131 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.

  • EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
  • Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
  • Net Income Multiple: Relevant for mature companies with stable results.

This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).

Similar companies (Autres activités de soutien aux entreprises n.c.a.)

Compare CENTRE D'EXPERTISE MEDICALE with other companies in the same sector:

Voir toutes les statistiques du secteur Autres activités de soutien aux entreprises n.c.a.

Frequently asked questions about CENTRE D'EXPERTISE MEDICALE

What is the revenue of CENTRE D'EXPERTISE MEDICALE ?

The revenue of CENTRE D'EXPERTISE MEDICALE in 2024 is 1.8 M€.

Is CENTRE D'EXPERTISE MEDICALE profitable?

CENTRE D'EXPERTISE MEDICALE recorded a net loss in 2024.

Where is the headquarters of CENTRE D'EXPERTISE MEDICALE ?

The headquarters of CENTRE D'EXPERTISE MEDICALE is located in BLAGNAC (31700), in the department Haute-Garonne.

Where to find the tax return of CENTRE D'EXPERTISE MEDICALE ?

The tax return of CENTRE D'EXPERTISE MEDICALE is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).

In which sector does CENTRE D'EXPERTISE MEDICALE operate?

CENTRE D'EXPERTISE MEDICALE operates in the sector Autres activités de soutien aux entreprises n.c.a. (NAF code 82.99Z). See the 'Sector positioning' section above to compare the company with its competitors.